Data / Form D filings / Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc.: Form D filings
Verrica Pharmaceuticals Inc., a pharmaceuticals company in West Chester, PA, filed 4 Form D notices with the SEC between 2015 and 2025. The latest, on December 10, 2025, reports $50 million sold of a $50 million offering to 21 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 44 W. Gay St., Suite 400, West Chester, PA, 19380
- Phone
- (484) 453-3300
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1660334
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 10, 2025 | New notice | $50,017,383 | $50,017,383 | 21 | Nov 25, 2025 | sec.gov | |
| Feb 21, 2018 | New notice | $21,000,000 | $19,999,995 | $1,000,005 | 2 | Feb 20, 2018 | sec.gov |
| Dec 22, 2017 | New notice | $5,000,000 | $5,000,000 | 1 | Dec 15, 2017 | sec.gov | |
| Dec 17, 2015 | New notice | Indefinite | $2,434,186 | 14 | Dec 2, 2015 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Mark B. Prygocki | Director | |
| Noah Rosenberg | Executive Officer | |
| Diem B. Nguyen | Director | |
| John Kirby | Executive Officer | |
| Gavin B. Corcoran | Director | |
| Jayson Rieger | Executive Officer, Director | |
| Paul B. Manning | Director | |
| David Zawitz | Executive Officer | |
| Lawrence B. Eichenfield | Director | |
| Sean B. Stalfort | Director |
Other pharmaceuticals companies in Pennsylvania that filed recently
- Telemachus Therapeutics, Inc. $375,000 · Oct 28, 2026
- EpiVario Inc. $185,000 · Oct 13, 2026
- Maxona Pharmaceuticals, Inc. $5.8 million · Aug 14, 2026
- PLEOPHARMA, INC. $5.5 million · Aug 10, 2026
- Duo Oncology Inc. $1.6 million · Aug 7, 2026
Every Form D from the week of Dec 8, 2025 · All recent filings in Pennsylvania · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Verrica Pharmaceuticals Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.